Skip to Content

Wayland Group Corp MRRCF

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

MRRCF is trading within a range we consider fairly valued.
Price
$0.00
Fair Value
$7.59
Uncertainty
Extreme
1-Star Price
$9.97
5-Star Price
$1.22
Economic Moat
Dnn
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if MRRCF is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.01
Market Cap
$139.88
Volume/Avg
200 / 3,918

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Wayland Group Corp is a Canada-based vertically integrated cultivator and processor of cannabis. It has production facilities in Langton, Ontario where it operates cannabis cultivation, extraction, formulation, and distribution business. The company also has production operations in Dresden, Saxony, Germany, Regensdorf, Switzerland and, Allesandria, Piedmont, Italy. It has a portfolio of medical and non-medical cannabis brands including Kiwi, Northern Harvest, High Tide, Solara, Maricann, and Lost at Seed.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Total Number of Employees

Valuation

Metric
MRRCF
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
MRRCF
Quick Ratio
0.99
Current Ratio
1.49
Interest Coverage
Quick Ratio
MRRCF

Profitability

Metric
MRRCF
Return on Assets (Normalized)
−34.24%
Return on Equity (Normalized)
−60.46%
Return on Invested Capital (Normalized)
−38.21%
Return on Assets
MRRCF
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AZqfdnfbzmJpjr$79.4 Bil
MKKGY
Merck KGaA ADRMpfnltfdjCmxrxs$79.0 Bil
HLN
Haleon PLC ADRPyhymxxZxzbg$38.5 Bil
VTRS
Viatris IncGvgclpxycJjxx$13.1 Bil
RDY
Dr Reddy's Laboratories Ltd ADRTltgdbrTwdhs$11.7 Bil
CTLT
Catalent IncYgsctfjhJvjbtvm$10.0 Bil
CURLF
Curaleaf Holdings IncKlphqrsyZcnq$4.2 Bil
PRGO
Perrigo Co PLCYshnwdqzsYfgy$4.1 Bil
PBH
Prestige Consumer Healthcare IncHmzlkhzkSnsrm$3.2 Bil
GTBIF
Green Thumb Industries IncQkfkdkrwjRjvy$3.1 Bil

Sponsor Center